Article: ChrysCap in race for ICICI Venture's stake in Intas.

Byline: Jeetha D'Silva

Nov. 15--MUMBAI, India -- Chryscapital and a host of other private equity firms such as Citicorp Venture Capital, Actis, Baring private equity and New Vernon Capital are in talks with ICICI Venture to buy the latter's 12.5 percent stake in Ahmedabad-based Intas Pharma, industry sources said.

Intas, with sales of Rs 381.1 crore, is ranked among the top 50 companies in the domestic pharmaceutical market. Industry sources added that ChrysCapital has already signed a deal to buy the ICICI stake at about Rs 55 crore. ICICI had bought the stake in 1996 and has been looking to exit for some time now.

A senior official at ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!